Redox regulation of endothelial function and wound healing
内皮功能和伤口愈合的氧化还原调节
基本信息
- 批准号:7082357
- 负责人:
- 金额:$ 24.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Wound healing impairment in diabetic patients represents a particular challenging clinical problem to which no efficacious treatment regimens exist. Endothelial cell dysfunction is a significant contributor to impaired wound healing. A cardinal feature of endothelial dysfunction in diabetes is hyperglycemia- mediated superoxide anion overproduction by the mitochondrial electron transport chain with resultant oxidative stress. Our preliminary data suggest that increased superoxide in diabetes appears to impair the functions of three endothelial factors on wound healing - tetrahydrobiopterin (BH4) and endothelial nitric oxide synthase (eNOS), endothelial morphogen sonic hedgehog (SHH), and endothelial progenitor cells (EPCs). Yet remarkably little is known about how superoxide-induced oxidative stress regulates these factors central to wound repair. Such knowledge is critical for successfully modulating endothelial function to improve wound healing in diabetes. For example, discovery of the defects in diabetic EPC and the means to correct them could lead to autologous cell therapies for diabetic wounds. This project will focus on oxidative stress-induced endothelial dysfunction in diabetic wound repair, thus filling a significant gap in such knowledge. We hypothesize that oxidative stress in diabetic wounds is a common cause for the dysfunction of the three repair mediators - eNOS, sonic hedgehog and endothelial progenitor cells, resulting in impaired healing. To test this hypothesis, we will pursue three specific aims using streptozotocin-induced type 1 diabetic mice. In aim 1, we will determine how oxidative stress impairs cutaneous eNOS function, focusing on the role of its essential cofactor BH4. In Aim 2, we will determine the mechanism through which sonic hedgehog regulates diabetic wound healing under oxidative stress. In Aim 3, we will determine how endothelial progenitor cells become dysfunctional in type 1 diabetes. The major significance of the proposed studies is that it will for the first time determine how superoxide regulates endothelial function and wound repair in an integrated fashion, which may provide new knowledge regarding an interconnected mechanism that affects wound healing in type 1 diabetes, thus addressing a fundamental issue in system biology and pathophysiology of wound healing.
描述(由申请人提供):糖尿病患者的伤口愈合障碍代表了一个特殊的具有挑战性的临床问题,对此不存在有效的治疗方案。内皮细胞功能障碍是伤口愈合受损的重要原因。糖尿病内皮功能障碍的一个主要特征是高血糖介导的线粒体电子传递链过度产生超氧阴离子,从而产生氧化应激。我们的初步数据表明,糖尿病中超氧化物的增加似乎会损害三种内皮因子对伤口愈合的功能——四氢生物蝶呤(BH4)和内皮一氧化氮合酶(eNOS)、内皮形态发生素音刺猬(SHH)和内皮祖细胞(EPC) 。然而,人们对超氧化物诱导的氧化应激如何调节这些对伤口修复至关重要的因素知之甚少。这些知识对于成功调节内皮功能以改善糖尿病伤口愈合至关重要。例如,发现糖尿病 EPC 的缺陷以及纠正这些缺陷的方法可能会导致糖尿病伤口的自体细胞疗法。该项目将重点研究糖尿病伤口修复中氧化应激诱导的内皮功能障碍,从而填补此类知识的重大空白。我们推测,糖尿病伤口中的氧化应激是导致三种修复介质(eNOS、音刺猬和内皮祖细胞)功能障碍的常见原因,从而导致愈合受损。为了检验这一假设,我们将使用链脲佐菌素诱导的 1 型糖尿病小鼠来追求三个特定目标。在目标 1 中,我们将确定氧化应激如何损害皮肤 eNOS 功能,重点关注其必需辅助因子 BH4 的作用。在目标 2 中,我们将确定 sonic hedgehog 在氧化应激下调节糖尿病伤口愈合的机制。在目标 3 中,我们将确定 1 型糖尿病中内皮祖细胞如何变得功能障碍。拟议研究的主要意义在于,它将首次确定超氧化物如何以综合方式调节内皮功能和伤口修复,这可能提供有关影响 1 型糖尿病伤口愈合的相互关联机制的新知识,从而解决伤口愈合的系统生物学和病理生理学的基本问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alex F Chen其他文献
R-spondin 3 Inhibits High Glucose-Induced Endothelial Activation Through Leucine-Rich G Protein-Coupled Receptor 4/Wnt/β-catenin Pathway.
R-spondin 3 通过富含亮氨酸的 G 蛋白偶联受体 4/Wnt/β-连环蛋白途径抑制高葡萄糖诱导的内皮激活。
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Chong Chen;Hang Qu;Fang Liu;Yu Yu;Kun Sun;Alex F Chen - 通讯作者:
Alex F Chen
PhospholipaseCγ1/calcium-dependent membranous localization of Gsdmd-N drives endothelial pyroptosis, contributing to lipopolysaccharide-induced fatal outcome
Gsdmd-N 的磷脂酶Cγ1/钙依赖性膜定位驱动内皮细胞焦亡,导致脂多糖诱导的致命结果
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Hong Liu;Da Tang;Xiaoyu Zhou;Xiaoping Yang;Alex F Chen - 通讯作者:
Alex F Chen
Alex F Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alex F Chen', 18)}}的其他基金
MicroRNA Regulation of Endothelial Progenitor Cell Function and Wound Healing
MicroRNA 对内皮祖细胞功能和伤口愈合的调节
- 批准号:
8974189 - 财政年份:2013
- 资助金额:
$ 24.61万 - 项目类别:
MicroRNA Regulation of Endothelial Progenitor Cell Function and Wound Healing
MicroRNA 对内皮祖细胞功能和伤口愈合的调节
- 批准号:
8976093 - 财政年份:2013
- 资助金额:
$ 24.61万 - 项目类别:
Tetrahydrobiopterin & eNOS uncoupling regulation of EPC function and wound healin
四氢生物蝶呤
- 批准号:
8466772 - 财政年份:2010
- 资助金额:
$ 24.61万 - 项目类别:
Tetrahydrobiopterin & eNOS uncoupling regulation of EPC function and wound healin
四氢生物蝶呤
- 批准号:
7870828 - 财政年份:2010
- 资助金额:
$ 24.61万 - 项目类别:
Tetrahydrobiopterin & eNOS uncoupling regulation of EPC function and wound healin
四氢生物蝶呤
- 批准号:
8838109 - 财政年份:2010
- 资助金额:
$ 24.61万 - 项目类别:
Tetrahydrobiopterin & eNOS uncoupling regulation of EPC function and wound healin
四氢生物蝶呤
- 批准号:
8840049 - 财政年份:2010
- 资助金额:
$ 24.61万 - 项目类别:
Redox regulation of endothelial function and wound healing
内皮功能和伤口愈合的氧化还原调节
- 批准号:
7839648 - 财政年份:2006
- 资助金额:
$ 24.61万 - 项目类别:
Redox regulation of endothelial function and wound healing
内皮功能和伤口愈合的氧化还原调节
- 批准号:
7234132 - 财政年份:2006
- 资助金额:
$ 24.61万 - 项目类别:
Redox regulation of endothelial function and wound healing
内皮功能和伤口愈合的氧化还原调节
- 批准号:
7922495 - 财政年份:2006
- 资助金额:
$ 24.61万 - 项目类别:
相似国自然基金
糖脂代谢紊乱疾病灵长类动物模型构建与DNA/RNA编辑介导的基因治疗方法开发
- 批准号:91957122
- 批准年份:2019
- 资助金额:82.0 万元
- 项目类别:重大研究计划
相似海外基金
A cell model of YARS2-associated childhood-onset mitochondrial disease
YARS2 相关的儿童期发病线粒体疾病的细胞模型
- 批准号:
10575369 - 财政年份:2023
- 资助金额:
$ 24.61万 - 项目类别:
Investigating human cis-regulatory evolution with hybrid iPS cells
用混合 iPS 细胞研究人类顺式调控进化
- 批准号:
10342219 - 财政年份:2022
- 资助金额:
$ 24.61万 - 项目类别:
Investigating human cis-regulatory evolution with hybrid iPS cells
用混合 iPS 细胞研究人类顺式调控进化
- 批准号:
10627747 - 财政年份:2022
- 资助金额:
$ 24.61万 - 项目类别:
SARM1 functional polymorphisms and their contribution to ALS risk
SARM1 功能多态性及其对 ALS 风险的影响
- 批准号:
10533327 - 财政年份:2021
- 资助金额:
$ 24.61万 - 项目类别:
Pharmacologic PTEN upregulation: A novel therapeutic approach to prevent pathological vascular remodeling and fibrosis
药理学 PTEN 上调:预防病理性血管重塑和纤维化的新治疗方法
- 批准号:
9756685 - 财政年份:2019
- 资助金额:
$ 24.61万 - 项目类别: